Legal NewsRoom
Menu
Menu
LEGAL NEWS
HOT TOPICS
LexisNexis® Legal Newsroom
ACA and Healthcare Reform
Antitrust and Unfair Competition
Banking and Finance
Bankruptcy
California
Climate Change
Constitutional Law and Civil Rights
Consumer Protection & Privacy
Contracts and Commercial Law
Corporate
Criminal Law and Procedure
Energy
Environmental
Estate and Elder Law
Family Law
Financial Fraud Law
Florida
Fracking and Alternative Energy
Health Care
Hot Topics
Hurricane Sandy
Illinois
Immigration Law
Immigration Reform
Insurance Law
Intellectual Property
International Law
International Trade
Labor and Employment Law
Law360
Legal Business
Lexis® Hub
Litigation
Mealeys
Media and Entertainment
Mergers and Acquisitions
New Jersey
New York
Pennsylvania
Public Contracts
Public media
Public Policy
Real Estate Law
Securities
Sports Law
Tax Law
Technology
Texas
Top Emerging Trends
Torts
Virtual Currency
Workers' Compensation
NEWS & INSIGHT
Blogs and Newsletters
BIZ Blog
Blog Mosaic
Business of Law Blog
Corporate Law Advisory
Legal Content Insider
LexTalk
State Net
®
Capitol Journal
News & Trending Topics
Law360
Legal Insights & Trends
Lexis Practice Advisor Journal
Professional Communities
Business Insight Solutions – Partner Portal
Corporate InfoPro (Corporate Information Professionals)
InfoPro (Legal Information Professionals)
LexisNexis
®
for Developers
Litigators Verdict & Settlement Exchange
VISIT LEXISNEXIS LEGAL & PROFESSIONAL
Search
Search
Please enter a Keyword
This should not be used for legal research but instead can be used to find solutions that will help you do legal research.
Sign In
Browse By Tags
antipsychotic
antipsychotic drug
anti-psychotic drug
class certification
diabetes
drug
drug makers
drugs
J.B. Van Hollen
lawsuit
Litigation
multidistrict litigation
New Jersey
New Jersey Attorney General
Nexium
off-label use
Patent
patent infringement
personal injury
Reference Manual On Scientific Evidence
Risperdal
Seroquel
settle
verdicts
Zyprexa
LexisNexis Emerging Issues Community Staff
over 12 years ago
Top Emerging Trends
Emerging Issues Law Blog
Legal News Video Update - May 10, 2010
Among the stories on this video edition of LexisNexis Legal News, numerous lawsuits have been filed as a result of the Gulf of Mexico oil spill and the U.S. Supreme Court hears oral arguments over whether those who signed a referendum petition opposing...
Tom Moylan
over 12 years ago
Litigation
Litigation Blog
AstraZeneca Agrees To Settle 17,500 Seroquel Cases For $198 Million
WILMINGTON, Del. — AstraZeneca announced Aug. 9 that it has reached agreements in principle to settle about 17,500 Seroquel claims in the United States for about $198 million. “The specific terms of the agreements, which are the result...
Tom Moylan
over 10 years ago
Litigation
Litigation Blog
N.J. Risperdal Jury Finds Diabetes Warning Lacking, But Drug Didn't Cause Disease
NEW BRUNSWICK, N.J. - (Mealey's) A Risperdal personal injury trial ended Feb. 16 in a defense verdict for Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. after a New Jersey state court jury found that Janssen failed to warn about the...
Tom Moylan
over 11 years ago
Litigation
Litigation Blog
AstraZeneca Pays States $68.5M For Off-Label Marketing Of Seroquel Antipsychotic
TRENTON, N.J. - (Mealey's) AstraZeneca Pharmaceuticals L.P. and AstraZeneca L.P. on March 10 agreed to pay $68.5 million to 37 states and the District of Columbia to resolve allegations in a New Jersey state court lawsuit that it marketed its atypical...
Tom Moylan
over 12 years ago
Litigation
Litigation Blog
AstraZeneca Settles Nearly 4,000 Seroquel Injury Claims; Terms Confidential
LONDON - (Mealey's) AstraZeneca PLC said July 29 that it has agreed in principle to settle with nearly 4,000 Seroquel product liability plaintiffs. The company said settlement terms are confidential. In notes to its second-quarter financial...
William A. Ruskin
over 9 years ago
Litigation
Litigation Blog
William A. Ruskin: Comcast May Be A Class Action Game-Changer, But Not In Boston
By William A. Ruskin | In Comcast Corp. v Behrend , 133 S.Ct. 1426 (March 27, 2013) [ enhanced opinion available to lexis.com subscribers ], the Supreme Court held that the lower court erred in failing to consider flaws in plaintiffs' damages model...
Tom Moylan
over 10 years ago
Litigation
Litigation Blog
Kentucky Appeals Court Vacates $130 Million Drug-Pricing Verdicts, Says State Was 'Complicit'
FRANKFORT, Ky. - A Kentucky appeals court panel on Oct. 12 vacated verdicts totaling more than $130.7 million against two drug makers for publishing inflated average wholesale prices (AWPs), saying the Kentucky Medicaid program was well aware of the practice...
LexisNexis Litigation Resource Community Staff
over 12 years ago
Litigation
News Headlines
Wisconsin To Get $4 Million In Multistate Drug Lawsuit
MADISON Wis. – (AP) Attorney General J.B. Van Hollen said Tuesday that Wisconsin will get more than $4 million in a multistate settlement with drug manufacturer AstraZeneca. The drug maker allegedly marketed the anti-psychotic drug Seroquel for...
LexisNexis Litigation Resource Community Staff
over 11 years ago
Litigation
News Headlines
AstraZeneca Paying $68.5 Million In Seroquel Settlement
WASHINGTON, D.C. - (AP) AstraZeneca will pay $68.5 million as part of a multistate settlement over allegations that the drug developer promoted its blockbuster psychiatric drug Seroquel for insomnia, Alzheimer's and other unapproved uses. The New...
LexisNexis Litigation Resource Community Staff
over 12 years ago
Litigation
News Headlines
AstraZeneca Wins Patent Dispute Over Crestor
NEW YORK - (AP) AstraZeneca Plc said Tuesday it won a patent challenge brought against its blockbuster cholesterol drug Crestor by generic drug developers. The U.S. District Court in Delaware ruled that a key patent on the company's third best-selling...
LexisNexis Litigation Resource Community Staff
over 12 years ago
Litigation
News Headlines
AstraZeneca Pays $198M To Settle Seroquel Lawsuits
LONDON - (AP) AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. Full version available to lexis.com subscriber .
LexisNexis Litigation Resource Community Staff
over 11 years ago
Litigation
News Headlines
AstraZeneca Settles Patent Litigation With Handa
LONDON - (AP) Drug maker AstraZeneca says it has reached an agreement with a U.S. company to settle patent infringement litigation. AstraZeneca said Friday that Handa Pharmaceuticals of Fremont, California had accepted that AstraZeneca had valid patents...